Advertisement
Screener

ABEONA THERAPEUTICS INC. (ABEO) Share-based Payment Arrangement, Expense

2.8 / 5 stars · 68/120 Roast Me

ABEONA THERAPEUTICS INC. Share-based Payment Arrangement, Expense

ABEONA THERAPEUTICS INC. (ABEO) reported Share-based Payment Arrangement, Expense of $3.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-13

  • ABEONA THERAPEUTICS INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.37M, a 19.05% increase year-over-year.
  • ABEONA THERAPEUTICS INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $2.96M, a 9.48% increase year-over-year.
  • ABEONA THERAPEUTICS INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $2.56M, a 30.90% increase year-over-year.
  • ABEONA THERAPEUTICS INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $2.69M, a 49.06% increase year-over-year.
  • ABEONA THERAPEUTICS INC. share-based payment arrangement, expense for fiscal 2025 was $10.78M, a 62.63% increase from fiscal 2024.
  • ABEONA THERAPEUTICS INC. share-based payment arrangement, expense for fiscal 2024 was $6.63M, a 39.01% increase from fiscal 2023.
  • ABEONA THERAPEUTICS INC. share-based payment arrangement, expense for fiscal 2023 was $4.77M, a 56.28% increase from fiscal 2022.
  • ABEONA THERAPEUTICS INC. share-based payment arrangement, expense for fiscal 2022 was $3.05M, a 65.78% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 3 month as first filedShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 6 month as first filedShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 9 month as first filedShare-based Payment Arrangement, Expense 12 monthShare-based Payment Arrangement, Expense 12 month as first filed
2026-06-30$3.37M
10-Q · filed 2026-08-13
$6.33M
10-Q · filed 2026-08-13
$8.88M
derived: sum of 3 quarters · filed 2026-08-13
$11.57M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$2.96M
10-Q · filed 2026-05-13
$5.52M
derived: sum of 2 quarters · filed 2026-05-13
$8.21M
derived: sum of 3 quarters · filed 2026-05-13
$11.04M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$2.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17
$5.25M
derived: sum of 2 quarters · filed 2026-03-17
$8.08M
derived: sum of 3 quarters · filed 2026-08-13
$10.78M
10-K · filed 2026-03-17
2025-09-30$2.69M
10-Q · filed 2025-11-12
$5.52M
derived: sum of 2 quarters · filed 2026-08-13
$8.22M
10-Q · filed 2025-11-12
$10.18M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$2.83M
10-Q · filed 2026-08-13
$5.53M
10-Q · filed 2026-08-13
$7.49M
derived: sum of 3 quarters · filed 2026-08-13
$9.29M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$2.70M
10-Q · filed 2026-05-13
$4.66M
derived: sum of 2 quarters · filed 2026-05-13
$6.46M
derived: sum of 3 quarters · filed 2026-05-13
$7.78M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$1.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17
$3.76M
derived: sum of 2 quarters · filed 2026-03-17
$5.08M
derived: sum of 3 quarters · filed 2026-03-17
$6.63M
10-K · filed 2026-03-17
2024-09-30$1.80M
10-Q · filed 2025-11-12
$3.13M
derived: sum of 2 quarters · filed 2025-11-12
$4.67M
10-Q · filed 2025-11-12
$6.19M
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$1.32M
10-Q · filed 2025-08-14
$2.87M
10-Q · filed 2025-08-14
$4.38M
derived: sum of 3 quarters · filed 2025-08-14
$5.94M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$1.55M
10-Q · filed 2025-05-15
$3.06M
derived: sum of 2 quarters · filed 2025-05-15
$4.62M
derived: sum of 3 quarters · filed 2025-05-15
$5.54M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20
$3.07M
derived: sum of 2 quarters · filed 2025-03-20
$4.00M
derived: sum of 3 quarters · filed 2025-03-20
$4.77M
10-K · filed 2025-03-20
2023-09-30$1.56M
10-Q · filed 2024-11-14
$2.48M
derived: sum of 2 quarters · filed 2024-11-14
$3.25M
10-Q · filed 2024-11-14
$4.09M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$927.00K
10-Q · filed 2024-08-12
$1.70M
10-Q · filed 2024-08-12
$2.53M
derived: sum of 3 quarters · filed 2024-08-12
$3.16M
derived: sum of 4 quarters · filed 2024-08-12
2023-03-31$770.00K
10-Q · filed 2024-05-15
$1.60M
derived: sum of 2 quarters · filed 2024-05-15
$2.23M
derived: sum of 3 quarters · filed 2024-05-15
$2.96M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$833.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18
$1.47M
derived: sum of 2 quarters · filed 2024-03-18
$2.19M
derived: sum of 3 quarters · filed 2024-03-18
$3.05M
10-K · filed 2024-03-18
2022-09-30$632.00K
10-Q · filed 2023-11-13
$1.36M
derived: sum of 2 quarters · filed 2023-11-13
$2.22M
10-Q · filed 2023-11-13
$4.22M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$724.00K
10-Q · filed 2023-08-08
$1.59M
10-Q · filed 2023-08-08
$3.59M
derived: sum of 3 quarters · filed 2023-08-08
$6.12M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$862.00K
10-Q · filed 2023-05-11
$2.86M
derived: sum of 2 quarters · filed 2023-05-11
$5.40M
derived: sum of 3 quarters · filed 2023-05-11
$7.83M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
$4.54M
derived: sum of 2 quarters · filed 2023-03-29
$6.97M
derived: sum of 3 quarters · filed 2023-03-29
$8.92M
10-K · filed 2023-03-29
$5.25M
10-K · filed 2022-03-31
2021-09-30$2.54M
10-Q · filed 2022-11-14
$4.96M
derived: sum of 2 quarters · filed 2022-11-14
$6.92M
10-Q · filed 2022-11-14
$3.80M
10-Q · filed 2021-11-15
$8.69M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$2.43M
10-Q · filed 2022-08-11
$4.38M
10-Q · filed 2022-08-11
$2.41M
10-Q · filed 2021-07-28
$6.15M
derived: sum of 3 quarters · filed 2022-08-11
$7.40M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$1.95M
10-Q · filed 2022-05-13
$1.08M
10-Q · filed 2021-05-17
$3.72M
derived: sum of 2 quarters · filed 2022-05-13
$4.97M
derived: sum of 3 quarters · filed 2022-05-13
$6.55M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
$3.02M
derived: sum of 2 quarters · filed 2022-03-31
$4.60M
derived: sum of 3 quarters · filed 2022-03-31
$5.85M
10-K · filed 2022-03-31
2020-09-30$1.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$2.83M
derived: sum of 2 quarters · filed 2021-11-15
$4.08M
10-Q · filed 2021-11-15
$5.81M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$1.58M
10-Q · filed 2020-08-10
$2.83M
10-Q · filed 2021-07-28
$4.57M
derived: sum of 3 quarters · filed 2021-05-17
$6.39M
derived: sum of 4 quarters · filed 2021-05-17
2020-03-31$1.26M
10-Q · filed 2021-05-17
$2.99M
derived: sum of 2 quarters · filed 2021-05-17
$4.81M
derived: sum of 3 quarters · filed 2021-05-17
$6.49M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$1.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24
$3.56M
derived: sum of 2 quarters · filed 2021-03-24
$5.24M
derived: sum of 3 quarters · filed 2021-03-24
$7.34M
10-K · filed 2021-03-24
2019-09-30$1.83M
10-Q · filed 2019-11-12
$3.50M
derived: sum of 2 quarters · filed 2020-08-10
$5.61M
10-Q · filed 2020-11-09
$6.71M
derived: sum of 4 quarters · filed 2020-08-10
2019-06-30$1.68M
10-Q · filed 2020-08-10
$3.78M
10-Q · filed 2020-08-10
$4.89M
derived: sum of 3 quarters · filed 2020-08-10
$7.39M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$2.10M
10-Q · filed 2020-05-06
$3.21M
derived: sum of 2 quarters · filed 2020-05-06
$5.71M
derived: sum of 3 quarters · filed 2020-05-06
$8.38M
derived: sum of 4 quarters · filed 2020-05-06
2018-12-31$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$3.60M
derived: sum of 2 quarters · filed 2020-03-16
$6.28M
derived: sum of 3 quarters · filed 2020-03-16
$8.18M
10-K · filed 2020-03-16
2018-09-30$2.50M
10-Q · filed 2019-11-12
$5.17M
derived: sum of 2 quarters · filed 2019-11-12
$7.07M
10-Q · filed 2019-11-12
$8.19M
derived: sum of 4 quarters · filed 2020-03-16
2018-06-30$2.67M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$4.57M
10-Q · filed 2019-08-09
$5.69M
derived: sum of 3 quarters · filed 2020-03-16
$6.48M
derived: sum of 4 quarters · filed 2020-03-16
2018-03-31$1.90M
10-Q · filed 2019-05-10
$3.02M
derived: sum of 2 quarters · filed 2020-03-16
$3.81M
derived: sum of 3 quarters · filed 2020-03-16
$5.05M
derived: sum of 4 quarters · filed 2020-03-16
2017-12-31$1.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
$1.91M
derived: sum of 2 quarters · filed 2020-03-16
$3.15M
derived: sum of 3 quarters · filed 2020-03-16
$4.64M
10-K · filed 2020-03-16
2017-09-30$792.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$2.04M
derived: sum of 2 quarters · filed 2018-11-09
$3.53M
10-Q · filed 2018-11-09
$4.46M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$2.73M
10-Q · filed 2018-08-09
$3.67M
derived: sum of 3 quarters · filed 2019-03-18
$4.59M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31$1.49M
10-Q · filed 2018-05-10
$2.43M
derived: sum of 2 quarters · filed 2019-03-18
$3.34M
derived: sum of 3 quarters · filed 2019-03-18
$4.73M
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31$935.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$1.85M
derived: sum of 2 quarters · filed 2019-03-18
$3.24M
derived: sum of 3 quarters · filed 2019-03-18
$4.83M
10-K · filed 2019-03-18
2016-09-30$917.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14
$2.30M
derived: sum of 2 quarters · filed 2017-11-14
$3.89M
10-Q · filed 2017-11-14
$5.41M
derived: sum of 4 quarters · filed 2017-11-14
2016-06-30$1.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$2.98M
10-Q · filed 2017-08-14
$4.49M
derived: sum of 3 quarters · filed 2017-08-14
$5.95M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$1.59M
10-Q · filed 2017-05-15
$3.11M
derived: sum of 2 quarters · filed 2017-05-15
$4.56M
derived: sum of 3 quarters · filed 2017-05-15
$5.46M
derived: sum of 4 quarters · filed 2017-05-15
2015-12-31$1.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30
$2.97M
derived: sum of 2 quarters · filed 2017-03-30
$3.87M
derived: sum of 3 quarters · filed 2017-03-30
$4.37M
10-K · filed 2017-03-30
2015-09-30$1.45M
10-Q · filed 2015-11-16
$2.36M
derived: sum of 2 quarters · filed 2015-11-16
$2.85M
10-Q · filed 2016-11-14
$2.58M
10-Q · filed 2015-11-16
$2.73M
derived: sum of 4 quarters · filed 2016-03-30
2015-06-30$904.00K
10-Q · filed 2015-08-14
$1.13M
10-Q · filed 2016-08-15
$1.27M
derived: sum of 3 quarters · filed 2016-03-30
$1.45M
derived: sum of 4 quarters · filed 2016-03-30
2015-03-31$224.00K
10-Q · filed 2015-05-14
$370.00K
derived: sum of 2 quarters · filed 2016-03-30
$542.00K
derived: sum of 3 quarters · filed 2016-03-30
$734.00K
derived: sum of 4 quarters · filed 2016-03-30
2014-12-31$146.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30
$318.00K
derived: sum of 2 quarters · filed 2016-03-30
$510.00K
derived: sum of 3 quarters · filed 2016-03-30
$1.30M
10-K · filed 2016-03-30
2014-09-30$172.00K
10-Q · filed 2015-11-16
$364.00K
derived: sum of 2 quarters · filed 2015-11-16
$1.16M
10-Q · filed 2015-11-16
$1.24M
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30$192.00K
10-Q · filed 2015-08-14
$987.00K
10-Q · filed 2015-08-14
$1.07M
derived: sum of 3 quarters · filed 2015-08-14
$1.10M
derived: sum of 4 quarters · filed 2015-08-14
2014-03-31$795.00K
10-Q · filed 2015-05-14
$64.00K
10-Q · filed 2014-05-12
$880.00K
derived: sum of 2 quarters · filed 2015-05-14
$906.00K
derived: sum of 3 quarters · filed 2015-05-14
$1.16M
derived: sum of 4 quarters · filed 2015-05-14
2013-12-31$85.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
$111.00K
derived: sum of 2 quarters · filed 2015-03-31
$362.00K
derived: sum of 3 quarters · filed 2015-03-31
$439.00K
10-K · filed 2015-03-31
2013-09-30$26.00K
10-Q · filed 2014-11-14
$277.00K
derived: sum of 2 quarters · filed 2014-11-14
$354.00K
10-Q · filed 2014-11-14
$437.00K
derived: sum of 4 quarters · filed 2014-11-14
2013-06-30$251.00K
10-Q · filed 2014-08-14
$328.00K
10-Q · filed 2014-08-14
$411.00K
derived: sum of 3 quarters · filed 2014-08-14
$496.00K
derived: sum of 4 quarters · filed 2014-08-14
2013-03-31$77.00K
10-Q · filed 2014-05-12
$160.00K
derived: sum of 2 quarters · filed 2014-05-12
$245.00K
derived: sum of 3 quarters · filed 2014-05-12
$353.00K
derived: sum of 4 quarters · filed 2014-05-12
2012-12-31$83.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26
$168.00K
derived: sum of 2 quarters · filed 2014-03-26
$276.00K
derived: sum of 3 quarters · filed 2014-03-26
$390.00K
10-K · filed 2014-03-26
2012-09-30$85.00K
10-Q · filed 2013-11-14
$193.00K
derived: sum of 2 quarters · filed 2013-11-14
$307.00K
10-Q · filed 2013-11-14
$606.00K
derived: sum of 4 quarters · filed 2013-11-14
2012-06-30$108.00K
10-Q · filed 2013-08-14
$222.00K
10-Q · filed 2013-08-14
$521.00K
derived: sum of 3 quarters · filed 2013-08-14
$865.00K
derived: sum of 4 quarters · filed 2013-08-14
2012-03-31$114.00K
10-Q · filed 2013-05-15
$413.00K
derived: sum of 2 quarters · filed 2013-05-15
$757.00K
derived: sum of 3 quarters · filed 2013-05-15
$999.00K
derived: sum of 4 quarters · filed 2013-05-15
2011-12-31$299.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20
$643.00K
derived: sum of 2 quarters · filed 2013-03-20
$885.00K
derived: sum of 3 quarters · filed 2013-03-20
$1.07M
10-K · filed 2013-03-20
2011-09-30$344.00K
10-Q · filed 2012-11-14
$586.00K
derived: sum of 2 quarters · filed 2012-11-14
$767.00K
10-Q · filed 2012-11-14
2011-06-30$242.00K
10-Q · filed 2012-08-14
$423.00K
10-Q · filed 2012-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Evommune, Inc. (EVMN)United States$0.320B-5.10
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40